{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:22:46Z","timestamp":1707524566006},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,26]]},"DOI":"10.7759\/cureus.26345","type":"journal-article","created":{"date-parts":[[2022,6,26]],"date-time":"2022-06-26T17:20:47Z","timestamp":1656264047000},"source":"Crossref","is-referenced-by-count":0,"title":["Co-occurrence of Glycogen Storage Disease Type 2 and Congenital Myasthenic Syndrome Type 5 in a Pediatric Patient: A Case Report"],"prefix":"10.7759","author":[{"given":"Fawzia","family":"Al-Sharif","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed F","family":"Alamer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussein O","family":"Taher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raneem Y","family":"Gazzaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asma O","family":"AlRuwaithi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuleen T","family":"Miliany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed A","family":"Alrufaihi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah F","family":"Al Amer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Diagnosis and management of Pompe disease in Saudi Arabia","volume":"11","author":"Mahnashi M","year":"2021","unstructured":"Mahnashi M, Alshehri A, Cupler E, et al.. Diagnosis and management of Pompe disease in Saudi Arabia. Am J Med Med Sci. 2021, 11:373-381.","journal-title":"Am J Med Med Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/0972-2327.64645","article-title":"Repetitive compound muscle action potentials in electrophysiological diagnosis of congenital myasthenic syndromes: a case report and review of literature","volume":"13","author":"Kumar RS","year":"2010","unstructured":"Kumar RS, Kuruvilla A. Repetitive compound muscle action potentials in electrophysiological diagnosis of congenital myasthenic syndromes: a case report and review of literature. Ann Indian Acad Neurol. 2010, 13:139-141. 10.4103\/0972-2327.64645","journal-title":"Ann Indian Acad Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70201-7","article-title":"Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment","volume":"14","author":"Engel AG","year":"2015","unstructured":"Engel AG, Shen XM, Selcen D, Sine SM. Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment. Lancet Neurol. 2015, 14:420-434. 10.1016\/S1474-4422(14)70201-7","journal-title":"Lancet Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/ijns6010022","article-title":"A newborn screening, presymptomatically identified infant with late-onset Pompe disease: case report, parental experience, and recommendations","volume":"6","author":"Wang RY","year":"2020","unstructured":"Wang RY. A newborn screening, presymptomatically identified infant with late-onset Pompe disease: case report, parental experience, and recommendations. Int J Neonatal Screen. 2020, 6:22. 10.3390\/ijns6010022","journal-title":"Int J Neonatal Screen"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2014.00177","article-title":"Pompe disease: from pathophysiology to therapy and back again","volume":"6","author":"Lim JA","year":"2014","unstructured":"Lim JA, Li L, Raben N. Pompe disease: from pathophysiology to therapy and back again. Front Aging Neurosci. 2014, 6:177. 10.3389\/fnagi.2014.00177","journal-title":"Front Aging Neurosci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0019-4832(12)60067-4","article-title":"Two cases of Pompe's disease: case report and review of literature","volume":"64","author":"Jegadeeswari A","year":"2012","unstructured":"Jegadeeswari A, Amuthan V, Janarthanan RA, Murugan S, Balasubramanian S. Two cases of Pompe's disease: case report and review of literature. Indian Heart J. 2012, 64:214-216. 10.1016\/S0019-4832(12)60067-4","journal-title":"Indian Heart J"},{"key":"ref7","article-title":"Recent developments, utilization, and spending trends for Pompe disease therapies","volume":"5","author":"Guo J","year":"2012","unstructured":"Guo J, Kelton CM, Guo JJ. Recent developments, utilization, and spending trends for Pompe disease therapies. Am Health Drug Benefits. 2012, 5:182-189.","journal-title":"Am Health Drug Benefits"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/102326-co-occurrence-of-glycogen-storage-disease-type-2-and-congenital-myasthenic-syndrome-type-5-in-a-pediatric-patient-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:38:37Z","timestamp":1707507517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/102326-co-occurrence-of-glycogen-storage-disease-type-2-and-congenital-myasthenic-syndrome-type-5-in-a-pediatric-patient-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,26]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.26345","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,26]]}}}